Please provide your email address to receive an email when new articles are posted on . Two studies found that mass screening for atrial fibrillation in older adults does not reduce stroke. In one ...

Screening for atrial fibrillation (Afib) -- whether with ECG in office or via a wearable device -- cannot be recommended for middle age and older adults without symptoms. So reaffirmed the U.S.

The committee discussed the effects of atrial fibrillation. The clinical experts commented that earlier diagnosis of atrial fibrillation may reduce a person's risk of stroke because anticoagulation ...

Circular revealed its new Ring 2 smart ring at CES 2025 on Sunday. Its key feature is an FDA-approved ECG for detecting AFib, ...

Garmin has announced a new ECG app for AFibVenu 2 Plus smartwatch users. This app is cleared by the U. S. Food and Drug Administration (FDA) and allows anyone with the Venu 2 Plus to record their ...

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib) - an irregular, fast heartbeat that is ...

Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardiogram (ECG) devices increased the rate of diagnosis in patients 85 and older, but failed to show ...

On Friday, the Food and Drug Administration granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch.

The electrocardiogram built into recent Apple Watch models isn’t likely to give wearers false notifications that they have atrial fibrillation, a potentially dangerous heart condition. A clean bill of ...

Using the ECG on Apple Watch Series 4 is dead easy. Photo: Lewis Wallace/Cult of Mac Ed Dentel has become the poster child for the new ECG function of the Apple Watch. He installed the recent update ...

The external assessment group (EAG) did a systematic review to identify evidence on the diagnostic accuracy and clinical effectiveness of using the lead‑I ECG devices to detect atrial fibrillation.